Advances in Near-Infrared Fluorescent Probes for Targeted Imaging of Cutaneous Squamous Cell Carcinoma
Abstract Molecularly targeted near-infrared fluorescence imaging offers a promising approach to delineating cutaneous squamous cell carcinoma while preserving healthy tissue. This narrative review integrates target biology, probe chemistry, experimental performance, and translational development, with particular attention to epidermal growth factor receptor, integrins, vascular endothelial growth factor, interleukin-6 receptor, and emerging molecular and organelle targets. Antibody conjugates have visualized cutaneous squamous cell carcinoma xenografts and patient-derived tumor grafts, while activatable probes and ex vivo human-specimen imaging provide a bridge to pathology-linked assessment. Studies in oral and other cancers contribute transferable strategies for topical delivery, fluorescence lifetime imaging, dual recognition, and microenvironment-responsive activation. Comparative assessment connects each probe class with its recognition mechanism, acquisition conditions, and reported biological or imaging end points. Photothermal, photodynamic, and photoimmunotherapy systems illustrate how imaging can be integrated with localized treatment and response monitoring. The review also identifies practical priorities for translation, including target accessibility, pharmacokinetics, construct-specific safety, calibrated acquisition, and prospective pathology-registered evaluation. These advances support the development of fluorescence-assisted localization and specimen assessment as complementary tools within established skin-cancer care.
Authors
- Youbai Chen (ORCID: https://orcid.org/0000-0003-4642-5795)
- Zheng Qing Zhao (ORCID: https://orcid.org/0000-0002-5536-0439)
- Yuguang Yang
- Chun Liang (ORCID: https://orcid.org/0000-0002-1851-2130)
- Hui Liu (ORCID: https://orcid.org/0000-0002-7648-0915)
- Libo Luo (ORCID: https://orcid.org/0009-0007-8495-1952)
- Huawei Liu (ORCID: https://orcid.org/0009-0000-1083-0727)
- Xiaoxue Li
- Yuzhang Wei
- Zeyang Wang
- Yi Yang
- Yihang Li
- Shuo Xu
- Gu A
- Wanwan Wang
Institutions
- Chinese PLA General Hospital (CN)
- Chinese University of Hong Kong, Shenzhen (CN)
- First Affiliated Hospital of Chinese PLA General Hospital (CN)
- Inner Mongolia Medical University (CN)
Publication Details
- Journal
- ACS Pharmacology & Translational Science
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1021/acsptsci.6c00469
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00